Howard G. Welgus

Director · 9 filings · Latest: Sep 15, 2026

Arcutis Biotherapeutics, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
ARQT	Howard Welgus	—	Oct 15, 2026	Proposed Sale	$26.93	4,728	$127.3K	—	Oct 15 7:56 PM
ARQT	Howard G. Welgus	Director	Sep 15, 2026	Sale	$24.18	4,730	$114.4K	35,841	Sep 17 8:06 PM
ARQT	Howard G. Welgus	Director	Sep 15, 2026	Option Exercise	$7.93	4,096	$32.5K	40,571	Sep 17 8:06 PM
ARQT	Howard Welgus	—	Sep 15, 2026	Proposed Sale	$24.18	4,730	$114.4K	—	Sep 15 8:03 PM
ARQT	Howard G. Welgus	Director	Aug 17, 2026	Sale	$26.18	4,730	$123.8K	36,475	Aug 19 8:57 PM
ARQT	Howard G. Welgus	Director	Aug 17, 2026	Option Exercise	$7.93	4,096	$32.5K	41,205	Aug 19 8:57 PM
ARQT	Howard Welgus	—	Aug 17, 2026	Proposed Sale	$26.18	4,730	$123.8K	—	Aug 17 8:28 PM
ARQT	Howard G. Welgus	Director	Jul 15, 2026	Sale	$26.91	4,730	$127.3K	37,109	Jul 17 8:01 PM
ARQT	Howard G. Welgus	Director	Jul 15, 2026	Option Exercise	$7.93	4,096	$32.5K	41,839	Jul 17 8:01 PM
ARQT	Howard Welgus	—	Jul 15, 2026	Proposed Sale	$26.91	4,730	$127.3K	—	Jul 15 8:01 PM
ARQT	Howard G. Welgus	Director	Jun 17, 2026	Sale	$25.67	635	$16.3K	37,743	Jun 18 12:40 AM
ARQT	Howard G. Welgus	Director	Jun 15, 2026	Sale	$24.41	4,096	$100.0K	38,378	Jun 18 12:40 AM
ARQT	Howard G. Welgus	Director	Jun 15, 2026	Option Exercise	$7.93	4,096	$32.5K	42,474	Jun 18 12:40 AM
ARQT	Howard Welgus	—	Jun 17, 2026	Proposed Sale	$25.67	635	$16.3K	—	Jun 17 8:08 PM
ARQT	Howard Welgus	—	Jun 15, 2026	Proposed Sale	$24.41	4,096	$100.0K	—	Jun 15 8:11 PM
ARQT	Howard G. Welgus	Director	May 1, 2026	Sale	$22.99	7,144	$164.2K	32,600	May 6 12:21 AM
ARQT	Howard Welgus	—	May 1, 2026	Proposed Sale	$22.99	7,144	$164.2K	—	May 1 8:04 PM
ARQT	Howard G. Welgus	Director	Apr 1, 2026	Sale	$23.88	10,000	$238.8K	39,744	Apr 3 9:46 PM
ARQT	Howard Welgus	—	Apr 1, 2026	Proposed Sale	$23.88	10,000	$238.8K	—	Apr 1 8:02 PM
ARQT	Howard G. Welgus	Director	Mar 2, 2026	Sale	$25.65	10,000	$256.5K	49,744	Mar 4 9:16 PM

Page 1 of 2